Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes
Open accessAbstract
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by CAG expansion in the huntingtin gene, which adds a homopolymeric tract of polyglutamine (polyQ) to the encoded protein leading to the formation of toxic aggregates. Despite rapidly accumulating evidences supporting a role for intercellular transmission of protein aggregates, little is known about whether and how huntingtin (Htt) misfolding progresses through the brain. It has been recently reported that synthetic polyQ peptides and recombinant fragments of mutant Htt are readily internalized in cell cultures and able to seed polymerization of a reporter wild-type Htt. However, there is no direct evidence of aggregate transfer between cells and the mechanism has not been explored. By expressing recombinant fragments of mutant Htt in neuronal cells and in primary neurons, we found that aggregated fragments formed within one cell spontaneously transfer to neighbors in cell culture. We demonstrate that the intercellular spreading of the aggregates requires cell-cell contact and does not occur upon aggregate secretion. Interestingly, we found that the expression of mutant, but not wild-type Htt fragments, increases the number of tunneling nanotubes, which in turn provide an efficient mechanism of transfer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Huntington's disease, actin remodeling promotes tunneling nanotube formation, with Rhes-driven tunnels and TNTs facilitating intercellular transfer of mutant huntingtin and polyglutamine aggregates.
“In HD, actin remodeling promotes TNT formation, with Rhes-driven “Rhes tunnels” and TNTs facilitating intercellular transfer of mutant huntingtin and polyglutamine aggregates, potentially complementing EV-mediated export observed in patient biofluids (Figure 3C) [186,187,188].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [187]
Mutant HTT propagates between neurons via tunneling nanotubes and extracellular vesicles, including exosomes carrying misfolded protein cargo.
“In addition to disrupted intracellular transport, accumulating evidence suggests that mutant HTT propagates between neurons via TNTs and EVs, including exosomes carrying misfolded protein cargo [186,187,196].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [187]
This TNT-mediated transfer potentially complements EV-mediated export observed in Huntington's disease patient biofluids.
“In HD, actin remodeling promotes TNT formation, with Rhes-driven “Rhes tunnels” and TNTs facilitating intercellular transfer of mutant huntingtin and polyglutamine aggregates, potentially complementing EV-mediated export observed in patient biofluids (Figure 3C) [186,187,188].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [187]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 42 · Cited by 210
- Authors
- Costanzo, M., Abounit, S., Marzo, L., Danckaert, A., Chamoun, Z., Roux, P., & Zurzolo, C.
- Affiliations
- Institut Pasteur (FR)
- Corresponding author
- Zurzolo, Chiara
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2013-01-01
- Volume
- 126
- Issue
- Pt 16
- Pages
- 3678-85
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2091458985
- Cited by
- 210
- References
- 42
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 14 · 2023: 13 · 2022: 24 · 2021: 23 · 2020: 14 · 2019: 11 · 2018: 18 · 2017: 31 · 2016: 18 · 2015: 17 · 2014: 9 · 2013: 4
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- green
- pasteur.hal.science
- Licence
- other-oa
- Locations
- Journal of Cell Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Agence Nationale de la Recherche (ANR-09-NEUR-0002, ANR-09-BLAN-0122)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Keywords
- Huntington's disease, polyglutamine aggregates, huntingtin, tunneling nanotubes, cell-cell contact, neurons, CAG repeat expansion, protein misfolding, neurodegeneration
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Huntington Disease, Neurons, Peptides, Transfection, Nanotubes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review